Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1990 May;80(5):545–550. doi: 10.2105/ajph.80.5.545

Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

A G Randolph 1, A E Washington 1
PMCID: PMC1404639  PMID: 2109544

Abstract

To evaluate the cost and benefits of screening tests for Chlamydia trachomatis in adolescent males, we developed a decision analysis model and compared the leukocyte esterase urine dipstick test with culture, with direct-smear fluorescent antibody (DFA), and with the option of no screening (no treatment). The leukocyte esterase test has the lowest average cost-per-cure ($51) compared with direct-smear fluorescent antibody ($192) and culture ($414). Compared with the DFA, we estimate that the leukocyte esterase test saves over $9,727 per cohort of 1,000 sexually active adolescent males screened. Sensitivity analyses show the leukocyte esterase test results in a lower cost-per-cure and lower overall costs (per cohort) than culture and direct-smear fluorescent antibody at any prevalence of C. trachomatis infection, and lower overall costs (per cohort) than no screening at prevalences above 21 percent.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adger H., Shafer M. A., Sweet R. L., Schachter J. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination. Lancet. 1984 Oct 27;2(8409):944–945. doi: 10.1016/s0140-6736(84)91164-4. [DOI] [PubMed] [Google Scholar]
  2. Alexander E. R., Harrison H. R. Role of Chlamydia trachomatis in perinatal infection. Rev Infect Dis. 1983 Jul-Aug;5(4):713–719. doi: 10.1093/clinids/5.4.713. [DOI] [PubMed] [Google Scholar]
  3. Chacko M. R., Lovchik J. C. Chlamydia trachomatis infection in sexually active adolescents: prevalence and risk factors. Pediatrics. 1984 Jun;73(6):836–840. [PubMed] [Google Scholar]
  4. Chambers C. V., Shafer M. A., Adger H., Ohm-Smith M., Millstein S. G., Irwin C. E., Jr, Schachter J., Sweet R. Microflora of the urethra in adolescent boys: relationships to sexual activity and nongonococcal urethritis. J Pediatr. 1987 Feb;110(2):314–321. doi: 10.1016/s0022-3476(87)80180-4. [DOI] [PubMed] [Google Scholar]
  5. Handsfield H. H., Jasman L. L., Roberts P. L., Hanson V. W., Kothenbeutel R. L., Stamm W. E. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA. 1986 Apr 4;255(13):1730–1734. [PubMed] [Google Scholar]
  6. Hipp S. S., Han Y., Murphy D. Assessment of enzyme immunoassay and immunofluorescence tests for detection of Chlamydia trachomatis. J Clin Microbiol. 1987 Oct;25(10):1938–1943. doi: 10.1128/jcm.25.10.1938-1943.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hook E. W., 3rd, Brady W. E., Reichart C. A., Upchurch D. M., Sherman L. A., Wasserheit J. N. Determinants of emergence of antibiotic-resistant Neisseria gonorrhoeae. J Infect Dis. 1989 May;159(5):900–907. doi: 10.1093/infdis/159.5.900. [DOI] [PubMed] [Google Scholar]
  8. Jay S., Litt I. F., Durant R. H. Compliance with therapeutic regimens. J Adolesc Health Care. 1984 Apr;5(2):124–136. doi: 10.1016/s0197-0070(84)80012-1. [DOI] [PubMed] [Google Scholar]
  9. Katz B. P., Danos C. S., Quinn T. S., Caine V., Jones R. B. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis. 1988 Jan-Mar;15(1):11–16. doi: 10.1097/00007435-198801000-00003. [DOI] [PubMed] [Google Scholar]
  10. Knapp J. S., Zenilman J. M., Biddle J. W., Perkins G. H., DeWitt W. E., Thomas M. L., Johnson S. R., Morse S. A. Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. J Infect Dis. 1987 Apr;155(4):819–822. doi: 10.1093/infdis/155.4.819. [DOI] [PubMed] [Google Scholar]
  11. Litt I. F., Cuskey W. R. Compliance with medical regimens during adolescence. Pediatr Clin North Am. 1980 Feb;27(1):3–15. doi: 10.1016/s0031-3955(16)33815-9. [DOI] [PubMed] [Google Scholar]
  12. Nettleman M. D., Jones R. B., Roberts S. D., Katz B. P., Washington A. E., Dittus R. S., Quinn T. S. Cost-effectiveness of culturing for Chlamydia trachomatis. A study in a clinic for sexually transmitted diseases. Ann Intern Med. 1986 Aug;105(2):189–196. doi: 10.7326/0003-4819-105-2-189. [DOI] [PubMed] [Google Scholar]
  13. O'Brien S. F., Bell T. A., Farrow J. A. Use of a leukocyte esterase dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees. Am J Public Health. 1988 Dec;78(12):1583–1584. doi: 10.2105/ajph.78.12.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Phillips R. S., Aronson M. D., Taylor W. C., Safran C. Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med. 1987 Aug;107(2):188–194. doi: 10.7326/0003-4819-107-2-188. [DOI] [PubMed] [Google Scholar]
  15. Sadof M. D., Woods E. R., Emans S. J. Dipstick leukocyte esterase activity in first-catch urine specimens. A useful screening test for detecting sexually transmitted disease in the adolescent male. JAMA. 1987 Oct 9;258(14):1932–1934. [PubMed] [Google Scholar]
  16. Sanders L. L., Jr, Harrison H. R., Washington A. E. Treatment of sexually transmitted chlamydial infections. JAMA. 1986 Apr 4;255(13):1750–1756. [PubMed] [Google Scholar]
  17. Shafer M. A., Prager V., Shalwitz J., Vaughan E., Moscicki B., Brown R., Wibbelsman C., Schachter J. Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis. 1987 Jul;156(1):223–224. doi: 10.1093/infdis/156.1.223. [DOI] [PubMed] [Google Scholar]
  18. Stamm W. E. Diagnosis of Chlamydia trachomatis genitourinary infections. Ann Intern Med. 1988 May;108(5):710–717. doi: 10.7326/0003-4819-108-5-710. [DOI] [PubMed] [Google Scholar]
  19. Stamm W. E., Koutsky L. A., Benedetti J. K., Jourden J. L., Brunham R. C., Holmes K. K. Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations. Ann Intern Med. 1984 Jan;100(1):47–51. doi: 10.7326/0003-4819-100-1-47. [DOI] [PubMed] [Google Scholar]
  20. Thompson S. E., Washington A. E. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev. 1983;5:96–123. doi: 10.1093/oxfordjournals.epirev.a036266. [DOI] [PubMed] [Google Scholar]
  21. Trachtenberg A. I., Washington A. E., Halldorson S. A cost-based decision analysis for Chlamydia screening in California family planning clinics. Obstet Gynecol. 1988 Jan;71(1):101–108. [PubMed] [Google Scholar]
  22. Washington A. E., Arno P. S., Brooks M. A. The economic cost of pelvic inflammatory disease. JAMA. 1986 Apr 4;255(13):1735–1738. [PubMed] [Google Scholar]
  23. Washington A. E., Browner W. S., Korenbrot C. C. Cost-effectiveness of combined treatment for endocervical gonorrhea. Considering co-infection with Chlamydia trachomatis. JAMA. 1987 Apr 17;257(15):2056–2060. [PubMed] [Google Scholar]
  24. Washington A. E., Johnson R. E., Sanders L. L., Jr Chlamydia trachomatis infections in the United States. What are they costing us? JAMA. 1987 Apr 17;257(15):2070–2072. [PubMed] [Google Scholar]
  25. Washington A. E., Sweet R. L., Shafer M. A. Pelvic inflammatory disease and its sequelae in adolescents. J Adolesc Health Care. 1985 Jul;6(4):298–310. doi: 10.1016/s0197-0070(85)80067-x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES